Mycobacterium tuberculosis lacking all mycolic acid cyclopropanation is viable but highly attenuated and hyperinflammatory in mice
- PMID: 22431648
- PMCID: PMC3370573
- DOI: 10.1128/IAI.00021-12
Mycobacterium tuberculosis lacking all mycolic acid cyclopropanation is viable but highly attenuated and hyperinflammatory in mice
Abstract
Mycolic acids, the major lipid of the Mycobacterium tuberculosis cell wall, are modified by cyclopropane rings, methyl branches, and oxygenation through the action of eight S-adenosylmethionine (SAM)-dependent mycolic acid methyltransferases (MAMTs), encoded at four genetic loci. Mycolic acid modification has been shown to be important for M. tuberculosis pathogenesis, in part through effects on the inflammatory activity of trehalose dimycolate (cord factor). Studies using the MAMT inhibitor dioctylamine have suggested that the MAMT enzyme class is essential for M. tuberculosis viability. However, it is unknown whether a cyclopropane-deficient strain of M. tuberculosis would be viable and what the effect of cyclopropane deficiency on virulence would be. We addressed these questions by creating and characterizing M. tuberculosis strains lacking all functional MAMTs. Our results show that M. tuberculosis is viable either without cyclopropanation or without cyclopropanation and any oxygenated mycolates. Characterization of these strains revealed that MAMTs are required for acid fastness and resistance to detergent stress. Complete lack of cyclopropanation confers severe attenuation during the first week after aerosol infection of the mouse, whereas complete loss of MAMTs confers attenuation in the second week of infection. Characterization of immune responses to the cyclopropane- and MAMT-deficient strains indicated that the net effect of mycolate cyclopropanation is to dampen host immunity. Taken together, our findings establish the immunomodulatory function of the mycolic acid modification pathway in pathogenesis and buttress this enzyme class as an attractive target for antimycobacterial drug development.
Figures
Similar articles
-
Trans-cyclopropanation of mycolic acids on trehalose dimycolate suppresses Mycobacterium tuberculosis -induced inflammation and virulence.J Clin Invest. 2006 Jun;116(6):1660-7. doi: 10.1172/JCI27335. J Clin Invest. 2006. PMID: 16741578 Free PMC article.
-
Redundant function of cmaA2 and mmaA2 in Mycobacterium tuberculosis cis cyclopropanation of oxygenated mycolates.J Bacteriol. 2010 Jul;192(14):3661-8. doi: 10.1128/JB.00312-10. Epub 2010 May 14. J Bacteriol. 2010. PMID: 20472794 Free PMC article.
-
Mycolic acid cyclopropanation is essential for viability, drug resistance, and cell wall integrity of Mycobacterium tuberculosis.Chem Biol. 2009 May 29;16(5):499-509. doi: 10.1016/j.chembiol.2009.04.001. Chem Biol. 2009. PMID: 19477414 Free PMC article.
-
[Biosynthesis and regulation of mycolic acids in Mycobacterium tuberculosis--a review].Wei Sheng Wu Xue Bao. 2012 Feb 4;52(2):146-51. Wei Sheng Wu Xue Bao. 2012. PMID: 22586991 Review. Chinese.
-
Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis.Clin Microbiol Rev. 2005 Jan;18(1):81-101. doi: 10.1128/CMR.18.1.81-101.2005. Clin Microbiol Rev. 2005. PMID: 15653820 Free PMC article. Review.
Cited by
-
Ample glycosylation in membrane and cell envelope proteins may explain the phenotypic diversity and virulence in the Mycobacterium tuberculosis complex.Sci Rep. 2019 Feb 27;9(1):2927. doi: 10.1038/s41598-019-39654-9. Sci Rep. 2019. PMID: 30814666 Free PMC article.
-
A Phenotypic Characterization of Two Isolates of a Multidrug-Resistant Outbreak Strain of Mycobacterium tuberculosis with Opposite Epidemiological Fitness.Biomed Res Int. 2020 Apr 8;2020:4741237. doi: 10.1155/2020/4741237. eCollection 2020. Biomed Res Int. 2020. PMID: 32337252 Free PMC article.
-
A novel mutation alters the stability of PapA2 resulting in the complete abrogation of sulfolipids in clinical mycobacterial strains.FASEB Bioadv. 2019 Apr 10;1(5):306-319. doi: 10.1096/fba.2018-00039. eCollection 2019 May. FASEB Bioadv. 2019. PMID: 32123834 Free PMC article.
-
Fragment-Based Ligand Discovery Applied to the Mycolic Acid Methyltransferase Hma (MmaA4) from Mycobacterium tuberculosis: A Crystallographic and Molecular Modelling Study.Pharmaceuticals (Basel). 2021 Dec 8;14(12):1282. doi: 10.3390/ph14121282. Pharmaceuticals (Basel). 2021. PMID: 34959681 Free PMC article.
-
Lipid-Centric Approaches in Combating Infectious Diseases: Antibacterials, Antifungals and Antivirals with Lipid-Associated Mechanisms of Action.Antibiotics (Basel). 2023 Dec 11;12(12):1716. doi: 10.3390/antibiotics12121716. Antibiotics (Basel). 2023. PMID: 38136750 Free PMC article. Review.
References
-
- Barry CE, III, et al. 1998. Mycolic acids: structure, biosynthesis and physiological functions. Prog. Lipid Res. 37:143–179 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources